Novavax
company in Gaithersburg, Maryland
Novavax, Inc., is an American biotechnology company based in Gaithersburg, Maryland that creates vaccines to fight against serious infectious diseases. Before to 2020, company scientists developed experimental vaccines for Ebola, influenza, respiratory syncytial virus (RSV), and other emerging infectious diseases.
During 2020, however, the company redirected its efforts to focus on development and approval of a vaccine for COVID-19.[1]
References change
- ↑ Novavax Inc. 2020 Annual Report Archived 2021-08-14 at the Wayback Machine. Accessed 10 May 2021.
This short article about the United States can be made longer. You can help Wikipedia by adding to it.